OZONE (O
) has long been known as an air pollutant originating from automobile emissions reacting with sunlight. Because of its potent oxidizing properties, O 3 inhalation results in airway and pulmonary injury leading to a severe state of inflammation characterized by recruitment of neutrophils and macrophages to the lung (10, 15, 21) . One of the most highly characterized effects of O 3 inhalation is airway hyperresponsiveness (AHR), a key symptom of asthma (9) . Although the consequences of O 3 inhalation are well characterized, the mechanism(s) by which O 3 induces AHR remain to be elucidated. (13) published their findings regarding Rho kinase's (ROCK) mediation of AHR observed in allergic asthma. They reported that insufficiency of either ROCK1 or ROCK2 resulted in a reduction in AHR without having an effect on inflammation. The article reviewed herein (14) extends these findings and sheds additional light into the mechanism of O 3 -induced AHR.
Two ROCK isoforms (ROCK1 and ROCK2) are presently identified. Both isoforms act as serine/threonine kinases, but they are thought to fulfill distinct roles due to their less homologous Rho binding domains (compared to their kinase domains). ROCK isoforms have been implicated in monocyte chemotaxis (18, 19) and fibronectin matrix assembly. Pertaining to the discussed article by Kasahara et al. (14) , ROCK isoforms are also implicated in regulating smooth muscle contractility (20) , as well as the allergic airway response in mice (26) . In addition, both ROCK isoforms have been shown to stimulate proliferation of vascular smooth muscle cells (VSMC) through the ERK pathway. Furthermore, leptin activation of RhoA/ROCK is known to lead to the development of VSMC hypertrophy (8, 23, 24) . Kasahara et al. (14) utilized wild-type (WT), ROCK1 ϩ/Ϫ , and ROCK2 ϩ/Ϫ haploinsufficient mice as well as the FDAapproved ROCK1/2 inhibitor fasudil (3 or 10 mg/kg) to determine ROCK's influence on O 3 -induced AHR. In this study, mice were exposed to O 3 at 2 ppm for 3 h then returned to room air. At 24 h postexposure, the investigators measured airway resistance prior to and following challenge with methacholine (MCh). Following challenge, various indexes of inflammation were also measured in the bronchoalveolar lavage (BAL) and lung tissue. Their results showed that O 3 -induced AHR occurs at least in part because of ROCK1 and ROCK2 activity. At 24 h post-O 3 exposure, there was a significant increase of the lung mechanic indexes, including Newtonian resistance, coefficient of lung tissue damping, coefficient of lung tissue elastance as well as lung resistance values in WT mice compared with their air control. These findings are consistent with previous observations and indicate the development of AHR (7) . However, these indexes were significantly lower in ROCK1 ϩ/Ϫ and ROCK2 ϩ/Ϫ mice exposed to O 3 . These results impressively showed that ROCK plays an important role in O 3 -induced AHR. For the four parameters of lung mechanics analyzed, the authors found that the ROCK1 ϩ/Ϫ and ROCK2 ϩ/Ϫ mice exposed to O 3 had statistically different responses from O 3 -exposed WT mice at the 30 mg/ml dose of MCh. However, it should be noted that no statistical significant difference was observed at any of the lower doses of MCh or at the highest dose at 100 mg/ml. Since the sample numbers varied widely between groups (5-12), the lack or presence of significance may be reflective of unequal power in the comparisons, which could be remedied by equalizing the n per group. Alternatively, if differences persist after equalizing power of analysis, including additional MCh doses between 10 and 30 mg/ml as well as between 30 and 100 mg/ml would further elucidate a range of challenge in which ROCK insufficiencies attenuate AHR.
Following up on the ROCK1 ϩ/Ϫ and ROCK2 ϩ/Ϫ lung mechanic data, Kasahara et al. (14) utilized the ROCK1/ ROCK2 inhibitor fasudil, which was administered intraperitoneally post-O 3 exposure (3 or 10 mg/kg, 30 min before flexiVent measurement). Fasudil has been utilized extensively to elucidate ROCK's roles in pulmonary hypertension and interactions with PPAR-␥, as well as in arterial endothelium of newborns (4, 8, 6) . The authors observed similar lung mechanic data as that seen with the ROCK1 ϩ/Ϫ and ROCK2 (26) . Correlating protein levels and activity in the genetic models and in fasudil-treated mice with the functional effects would allow for further interpretation of the large differences in physiological response between the two approaches.
Previous reports have shown that O 3 -induced AHR was influenced by IL-17A, TNF-␣, and osteopontin (1, 3, 17) . Pichavant et al. (17) claimed that repeated exposure of mice to O 3 -induced AHR required the production of IL-17A. Kasahara et al.'s results do, in fact, demonstrate that IL-17A, TNF-␣, and osteopontin are increased by exposure to O 3 . However, all mice (i.e., WT, ROCK1 ϩ/Ϫ , and ROCK2 ϩ/Ϫ ) exposed to O 3 had similar robust increases in IL-17A, TNF-␣, and osteopontin.
In another study, Zhou et al. (25) reported increased pulmonary Grpr mRNA following O 3 exposure and concluded that GRPR signaling was required for O 3 -induced AHR in WT mice. Kasahara et al. (14) noticed the same upregulation of Grpr mRNA by O 3 exposure. Again, no difference of Grpr exists between WT and ROCK1 ϩ/Ϫ and ROCK2 ϩ/Ϫ mice before and after exposure to O 3 .
Although this was not spelled out in the discussion, the most plausible explanation to these findings is that ROCK isoforms act downstream of IL-17A, TNF-␣, osteopontin, and Grpr in mediating AHR.
In addition to the aforementioned mediators, the authors' data also revealed a significantly lower BAL hyaluronan level in O 3 -exposed ROCK1 ϩ/Ϫ mice compared with O 3 -exposed WT mice. Kasahara et al. (14) thus concluded that ROCK1 insufficiency attenuated AHR by lowering airway hyaluronan levels, which have been associated with the development of lung injury. This is an interesting development in the field since multiple investigators have found a role for hyaluronan in lung injury. For example, Garantziotis et al. (7) demonstrated that low-molecular-weight hyaluronan, formed by the fragmentation of high-molecular-weight hyaluronan by reactive intermediates, was necessary for the development of O 3 -induced AHR. Most recently, Lazrak et al. (16) showed that low-molecular-weight hyaluronan was responsible for the depolarization of human airway smooth muscle cells and contributed to AHR in chlorine (Cl 2 )-exposed mice. Lazrak et al. suggest that the depolarization caused Ca 2ϩ influx and activation of RhoA and its downstream kinase (ROCK), which enhanced agonist-induced contraction via retention of myosin light chain in a phosphorylated state. Based on the data of Kasahara et al., the reduced AHR after O 3 exposure in ROCK1 ϩ/Ϫ mice was, at least, partially attributed to the lower level of hyaluronan, which was implied to be ROCK1 dependent. Interestingly, this is the first report to date that suggests the action of hyaluronan is downstream, rather than upstream of ROCK1. Therefore, the mechanism underlying this new finding warrants further study. On the other hand, Garantziotis and Lazrak also clearly showed that high-molecular-weight hyaluronan confers protection against O 3 -specific as well as Cl 2 -induced AHR. It should be noted that Kasahara et al. found no significant difference in BAL inflammatory cells and me- Fig. 1 . Possible pathways by which Rho-associated coiled-coil forming kinase (ROCK) mediates ozone (O3)-induced airway hyperresponsiveness (AHR). Following exposure to O3, activated RhoA-GTP binds to and activates ROCK isoforms (ROCK1 and ROCK2). ROCK1 potentially mediates AHR via hyaluronan signaling following O3 exposure. ROCK2 potentially mediates airway smooth muscle (ASM) contraction and subsequent AHR via phosphorylation of myosin light chain phosphatase (MLCP) independent of ROCK2's mediation of O3-induced lung injury. Solid black lines refer to previously established paths, dotted yellow lines refer to Kasahara et al.'s (14) proposed mechanisms by which each ROCK isoform is influenced by O3 exposure. Although reducing ROCK2 increased airway injury, Kasahara et al. have proposed that ROCK2's effect on airway injury is not the mechanism by which ROCK2 mediates the AHR. diators between WT and ROCK1 ϩ/Ϫ mice after O 3 exposure. Thus the mechanism underlying the decreased hyaluronan production in ROCK1 ϩ/Ϫ mice remains to be elucidated. In this study Kasahara et al. (14) demonstrated that exposure of WT mice to O 3 results in ϳ50% increase in pulmonary ROCK2 expression (from lung homogenate). Thus they are the first investigators to document the involvement of ROCK2 in O 3 toxicity and suggest the mechanism(s) involved. The authors proposed that the involvement of ROCK2 in O 3 -induced AHR is downstream of inflammation and at the level of smooth muscle contraction. They provided two novel pieces of evidence for ROCK2's involvement in lung injury following O 3 exposure. In agreement with previous findings, all three groups of O 3 -exposed mice (again WT, ROCK1 ϩ/Ϫ , and ROCK2 ϩ/Ϫ ) experienced substantial pulmonary epithelium/endothelium damage (increased BAL protein and epithelial cells) and inflammation (high levels of neutrophils and macrophages). Interestingly, O 3 exposure significantly increased BAL macrophages and epithelial cells in ROCK2 ϩ/Ϫ mice compared with O 3 -exposed WT and ROCK1 ϩ/Ϫ mice, whereas the other two markers of lung injury analyzed for (BAL neutrophils and protein) showed no difference between any of the O 3 -exposed groups. The BAL neutrophil data does, however, seem to trend upward in the O 3 -exposed ROCK2
ϩ/Ϫ mice, with a large variation that may be abrogated with a larger number of subjects (each group's n was between 4 and 11).
Following evidence of increased O 3 -induced lung damage in ROCK2 ϩ/Ϫ mice vs. WT mice, Kasahara et al. (14) showed a commensurate increase in BAL keratinocyte chemoattractant, MCP-1, as well as MIP-3a in ROCK2 ϩ/Ϫ mice compared with WT mice. ROCK1 ϩ/Ϫ mice, however, had no significant difference in inflammatory markers compared with WT mice following O 3 exposure. Thus cellular reductions in ROCK2 seemingly increase susceptibility to pulmonary inflammation following O 3 . These ROCK2 ϩ/Ϫ data interestingly demonstrate that, although ROCK2 is required for O 3 -induced AHR, ROCK2 participates in the aforementioned AHR independently, and even despite, its attenuating effects on O 3 -induced pulmonary inflammation.
This finding is reinforced with the author's utilization of human airway smooth muscle cells to demonstrate a decrease in contractile force following ROCK2 inhibition. This in vitro method exposed that ROCK2 mediates O 3 -induced AHR by tipping the balance of smooth muscle cells to a constricted state via inhibition of myosin light chain phosphatase (MLCP). The authors posit that, even amidst a higher level of inflammation and pulmonary damage following O 3 exposure, ROCK2 ϩ/Ϫ mice still demonstrate lower AHR. They thus suggested this diminished AHR is due to the reduced MLCP activity downstream of O 3 -induced inflammation and/or injury.
From 1999 when Iizuka et al. (12) determined that ROCK inhibited MLCP in rabbit trachea, to Hanazaki et al.'s (11) discovery in 2008 demonstrating ROCK inhibition enhances the ASM relaxed state initiated by propofol and Cazzola et al. (2) evidencing ROCK as a mechanism for enhanced responsiveness in human airway smooth muscle in 2012, ROCK's role in the contraction of smooth muscle is more widely known. Despite these findings, each ROCK isoform's role remains to be elucidated. Therefore, Kasahara et al.'s (14) use of the pan-ROCK inhibitor Y27632 and ROCK2-specific inhibitor SR3677 before exposure to contractile agonists does make headway into each isoform's role. A schematic of the mechanisms proposed in Kasahara's study is displayed in Figure 1 .
In summary, the study by Kasahara et al. discussed here provides further insight into the roles potentially played by ROCK isoform signaling in response to O 3 exposure. Research in this area is important because of increasingly frequent O 3 encounters, and this study provides useful insight into potential therapies following O 3 exposure to prevent AHR.
